<DOC>
	<DOCNO>NCT01220258</DOCNO>
	<brief_summary>One objective study determine level marker inflammation eyelid margin subject blepharoconjunctivitis compare healthy volunteer . Another objective determine subject blepharoconjunctivitis effect azithromycin ophthalmic solution , 1 % marker inflammation lid margin conjunctivae sign symptom blepharoconjunctivitis .</brief_summary>
	<brief_title>A Four Week , Open-Label Study Azithromycin Ophthalmic Solution , 1 % ( P08641 )</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have current diagnosis posterior blepharoconjunctivitis eye ( except healthy volunteer ) Have Best Corrected Visual Acuity ( BCVA ) , use corrective lens necessary , eye least +0.7 LogMAR If female , nonpregnant nonlactating Have anterior blepharitis Have lid structural abnormality Have penetrate intraocular surgery past 90 day require penetrate intraocular surgery study Unable withhold use contact lens within 3 day prior Visit 1 study Have diagnose ongoing glaucoma Have serious medical condition could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>